Cytodyn Inc (CYDY)

[Saltz]

Yeah, and it’s going to get a lot more expensive as the clinical data continues to stack up.

That’s the way it works. Market cap is relative to potential revenue and likelihood of FDA approval. CYDY’s MC is $500M. Longs understand what a bargain valuation that is for where Leronlimab is in the development cycle. You think it is absurd because you haven’t looked under the hood to understand the machinery. You look at it from a very simplistic perspective. One day you will wake up and say to yourself; WTF, how did I not see this coming.

Your stuck on the paint job. If you took some time out and looked under the hood you’d find a Ferrari Engine.